Dr. Mark Randolph Riser, DO

Dr. Riser practices at Landmark Medical Center in Woonsocket, Rhode Island, part of Prime Healthcare Services.

Dr. Riser's NPI, 1457309619, was assigned on May 4, 2006. Dr. Riser graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 1995. Dr. Riser holds New York license 268189-1.

Dr. Riser's primary practice is Landmark Medical Center, at 115 Cass Avenue, Woonsocket, RI 02895 in Providence County. The practice phone is (401) 769-4100.

Dr. Riser's primary practice is Landmark Medical Center in Woonsocket, Rhode Island, part of Prime Healthcare Services. Dr. Riser is also affiliated with Aspirus Rhinelander Hospital. The medical group on file is Emergency Associates of Woonsocket. Dmand AI also links Dr. Riser to 1 more hospital, 10 medical groups and 1 rural health clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Riser practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Riser's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Riser's licenses on file in 3 states: New York, North Carolina and Rhode Island.

CMS data shows 198 Medicare services from Dr. Riser across 6 procedure codes in 2024, for 197 Medicare patients. Medicare paid $16,262 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 197 Medicare patients who saw Dr. Riser in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Riser's median patient age at 51, with 58% women.

In 2024, Dr. Riser wrote 210 Medicare Part D claims for 142 patients. 93% of them were for generic drugs. CMS names the drug for 90 of them, across 4 drugs with 11 or more claims each, at $312 in total drug cost. In 2023, CMS named 66 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Riser for performance year 2024, reported as part of a group. Dr. Riser accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 11 general payments to Dr. Riser from 6 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. CSL Behring paid the most, $86.

Dr. Riser graduated from Kansas City University of Med & Biosciences, College of Osteo Med in 1995.